New drug R-5280 tested for safety in kids with type 1 diabetes
Disease control
Completed
This early-stage trial tested whether a new drug called R-5280 is safe and tolerable for children aged 11 to 17 who were recently diagnosed with type 1 diabetes. Nine participants received the drug or a placebo, and researchers monitored side effects, blood sugar levels, and gut …
Phase: PHASE1 • Sponsor: Rise Therapeutics LLC • Aim: Disease control
Last updated May 17, 2026 03:15 UTC